In terms of CD8+ T cells, cell infiltration in cases with NSCLC harboring mutation in FAT1 was significantly lower than that in patients with wild-type FAT1 (p = 0.005, Figure 2A). The gene discussed is FAT1; the disease is non-small cell lung carcinoma.